doi:10.3969/j.issn.1004-583X.2024.09.016

Abstract

CLC Number:

R692.5

Add to citation manager EndNote|Ris|BibTeX

URL: https://lchc.magtechjournal.com/EN/10.3969/j.issn.1004-583X.2024.09.016

https://lchc.magtechjournal.com/EN/Y2024/V39/I9/847

References 33

[1]	Ronco C, Bellomo R, Kellum JA. Acute kidney injury[J]. Lancet, 2019, 394(10212):1949-1964. doi: S0140-6736(19)32563-2 pmid: 31777389
[2]	Rey A, Gras-Champel V, Balcaen T, et al. Use of a hospital administrative database to identify and characterize community-acquired, hospital-acquired and drug-induced acute kidney injury[J]. J Nephrol, 2022, 35(3): 955-968.
[3]	Macedo E, Hemmila U, Sharma SK, et al. Recognition and management of community-acquired acute kidney injury in low-resource settings in the ISN 0by25 trial: A multi-country feasibility study[J]. PLoS Med, 2021, 18(1): e1003408.
[4]	Emmett L, Tollitt J, McCorkindale S, et al. The evidence of acute kidney injury in the community and for primary care interventions[J]. Nephron, 2017, 136(3): 202-210.
[5]	Hsu CY, McCulloch CE, Fan D, et al. Community-based incidence of acute renal failure[J]. Kidney Int, 2007, 72(2): 208-212. doi: 10.1038/sj.ki.5002297 pmid: 17507907
[6]	Stucker F, Ponte B, De la Fuente V, et al. Risk factors for community-acquired acute kidney injury in patients with and without chronic kidney injury and impact of its initial management on prognosis: A prospective observational study[J]. BMC Nephrol, 2017, 18(1): 380.
[7]	Diamantidis CJ, Zepel L, Smith VA, et al. Epidemiology of community-acquired acute kidney injury among US veterans[J]. Am J Kidney Dis, 2023, 82(3): 300-310. doi: 10.1053/j.ajkd.2023.01.448 pmid: 36963745
[8]	Hsu CN, Lee CT, Su CH, et al. Incidence, outcomes, and risk factors of community-acquired and hospital-acquired acute kidney injury: A retrospective cohort study[J]. Medicine (Baltimore), 2016, 95(19): e3674.
[9]	Wang Y, Wang J, Su T, et al. Community-acquired acute kidney injury: A nationwide survey in China[J]. Am J Kidney Dis, 2017, 69(5): 647-657. doi: S0272-6386(16)30671-0 pmid: 28117208
[10]	Kumar V, Jha V. Community-acquired AKI in Asia: An update[J]. Semin Nephrol, 2020, 40(5): 456-467. doi: 10.1016/j.semnephrol.2020.08.002 pmid: 33334459
[11]	Prasad N, Jaiswal A, Meyyappan J, et al. Community-acquired acute kidney injury in India: Data from ISN-acute kidney injury registry[J]. Lancet Reg Health Southeast Asia, 2024, 21:100359.
[12]	Francis A, Harhay MN, Ong ACM, et al. Chronic kidney disease and the global public health agenda: An international consensus[J]. Nat Rev Nephrol, 2024, 20(7):473-485.
[13]	Silver SA, Nadim MK, O'Donoghue DJ, et al. Community health care quality standards to prevent acute kidney injury and its consequences[J]. Am J Med, 2020, 133(5): 552-560.e3. doi: S0002-9343(19)31081-2 pmid: 31830434
[14]	Cely JE, Mendoza EJ, Sprockel JJ, et al. Risk factors for community-acquired acute kidneyinjury in medical patients: A nested case-control study[J]. Blood Purif, 2020, 49(6): 677-684.
[15]	Shemiesa RS, Abdelsalama M, Elnagara SS, et al. Characteristics, risk factors and outcomes of community-acquired acute kidney injury in the elderly: A prospective tertiary hospital study, Egypt[J]. Afr Health Sci, 2022, 22(2): 350-361. doi: 10.4314/ahs.v22i2.40 pmid: 36407403
[16]	Hu W, Lian X, Lin J, et al. The incidence, characteristics, and use of suspected nephrotoxic drugs in elderly patients with community-acquired acute kidney injury[J]. Clin Interv Aging, 2021, 16: 35-42. doi: 10.2147/CIA.S286660 pmid: 33442243
[17]	Tso M, Sud K, Van C, et al. Clinical characteristics and outcomes of community acquired-acute kidney injury[J]. Int Urol Nephrol, 2023, 55(9): 2345-2354. doi: 10.1007/s11255-023-03533-0 pmid: 36892813
[18]	Robert L, Ficheur G, Gautier S, et al. Community-acquired acute kidney injury induced by drugs in older patients: A multifactorial event[J]. Clin Interv Aging, 2019, 14: 2105-2113. doi: 10.2147/CIA.S217567 pmid: 31824141
[19]	Rey A, Gras V, Moragny J, et al. Use of the capture-recapture method to estimate the frequency of community- and hospital-acquired drug-induced acute kidney injuries in French databases[J]. Front Pharmacol, 2022, 13: 899164.
[20]	Duong H, Tesfaye W, Van C, et al. Hospitalisation due to community-acquired acute kidney injury and the role of medications: A retrospective audit[J]. J Clin Med, 2023, 12(9): 3347.
[21]	Khwaja A. KDIGO clinical practice guidelines for acute kidney injury[J]. Nephron Clin Pract, 2012, 120(4): c179-184.
[22]	Duong H, Tesfaye W, Van C, et al. Sick day management in people with chronic kidney disease: A scoping review[J]. J Nephrol, 2023, 36(5): 1293-1306.
[23]	Watson KE, Dhaliwal K, McMurtry E, et al. Sick day medication guidance for people with diabetes, kidney disease, or cardiovascular disease: A systematic scoping review[J]. Kidney Med, 2022, 4(9): 100491.
[24]	Mehta RL, Cerdá J, Burdmann EA, et al. International society of nephrology's 0by25 initiative for acute kidney injury (zero preventable deaths by 2025): A human rights case for nephrology[J]. Lancet, 2015, 385(9987): 2616-2643. doi: 10.1016/S0140-6736(15)60126-X pmid: 25777661
[25]	Naqvi R, Huma A. Community acquired acute kidney injury in South Asia: Causes and outcome. A meta-analysis[J]. J Pak Med Assoc, 2023, 73(2): 333-337. doi: 10.47391/JPMA.7554 pmid: 36800721
[26]	Gross C, Miao Jonasson J, Buchebner D, et al. Prognosis and mortality within 90 days in community-acquired acute kidney injury in the Southwest of Sweden[J]. BMC Nephrol, 2023, 24(1): 171.
[27]	Xu X, Nie S, Liu Z, et al. Epidemiology and clinical correlates of AKI in Chinese hospitalized adults[J]. Clin J Am Soc Nephrol, 2015, 10(9): 1510-1518.
[28]	Medina KRP, Jeong JC, Ryu JW, et al. Comparison of outcomes of mild and severe community- and hospital-acquired acute kidney injury[J]. Yonsei Med J, 2022, 63(10): 902-907. doi: 10.3349/ymj.2021.0238 pmid: 36168242
[29]	Wonnacott A, Meran S, Amphlett B, et al. Epidemiology and outcomes in community-acquired versus hospital-acquired AKI[J]. Clin J Am Soc Nephrol, 2014, 9(6): 1007-1014.
[30]	Huang L, Xue C, Kuai J, et al. Clinical characteristics and outcomes of community-acquired versus hospital-acquired acute kidney injury: A meta-analysis[J]. Kidney Blood Press Res, 2019, 44(5): 879-896.
[31]	Inokuchi R, Hara Y, Yasuda H, et al. Differences in characteristics and outcomes between community- and hospital-acquired acute kidney injury: A systematic review and meta-analysis[J]. Clin Nephrol, 2017, 88(10): 167-182.
[32]	Campbell CA, Li L, Kotwal S, et al. Under-detection of acute kidney injury in hospitalised patients: A retrospective, multi-site, longitudinal study[J]. Intern Med J, 2020, 50(3): 307-314. doi: 10.1111/imj.14264 pmid: 30816607
[33]	Alwagdani A, Awad AS, Abdel-Rahman EM. Optimum post-discharge care of acute kidney injury (AKI) survivors[J]. J Clin Med, 2022, 11(21):6277.

RichHTML

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 33

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Zhang Hui, Zhang Wenbo, Liang Wenqi, Huo Yanhong. Idiopathic renal hypouricemia combined with repeated acute kidney injury: A case report and literature review [J]. Clinical Focus, 2025, 40(2): 168-171.
[2]	Pu Qian, Cheng Gang, Dao Jiecao, Qi Zizhao, Dou Lele, Zhao Junfang, Zhang Wenjun, Guo Caixia, Wang Yingying. Risk factors for constipation in patients with chronic kidney disease in Gansu province: a single-center study [J]. Clinical Focus, 2025, 40(1): 44-53.
[3]	Liu Yi, Zhao Haotian, Wang Xiaona, Liu Yuanlin, Li Li, Wang Zekai. Application value of right heart ultrasound combined with renal vascular doppler score in patients with end-stage renal disease during dialysis [J]. Clinical Focus, 2025, 40(1): 54-59.
[4]	Guo Xiaocui, Yu Xiaojuan, Shen Xia, Ye Shuiying, Zhou Dongchi, Lai Bihong. Effect of a multidisciplinary intervention on the quality of life in maintenance hemodialysis patients [J]. Clinical Focus, 2024, 39(9): 803-807.
[5]	. [J]. Clinical Focus, 2024, 39(2): 183-187.
[6]	Wang Lingling, Wu Jinlan, Wu Wei, Shen Shipeng, Chi Yanqing, Liu Maodong. A meta-analysis of the renal protective effects of vitamin D and its analogues in non dialysis patients with chronic kidney disease [J]. Clinical Focus, 2022, 37(12): 1081-1088.
[7]	Wang Pengrui, Chen Huaqian, Yang Tao, Zhao Li, Li Peng. The effect of serum intact parathyroid hormone level on the maturation of autogeneous arteriovenous fistula [J]. Clinical Focus, 2022, 37(12): 1094-1098.
[8]	Li Yingying, Li Ting, Zhang Ming, Fan Minghua, Xing Guangqun. Monitoring significance of CD4⁺ T lymphocyte count on evaluating frailty status of chronic renal failure in patients [J]. Clinical Focus, 2022, 37(3): 243-247.
[9]	Li Wenzhe, Shang Jinchun, Li Chunmei, Tian Fen, Li Jun, Cui Li, Xing Guangqun. Risk factors of cerebral hemorrhage in uremic patients on regular hemodialysis [J]. Clinical Focus, 2022, 37(1): 20-25.
[10]	Li Wenzhe, Shang Jinchun, Li Chunmei, Li Jun, Tian Fen, Cui Li, Chen Yipeng, Zhang Xiaofan, Xing Guangqun. Effect of sodium citrate anticoagulation in continuous renal replacement therapy on uremic patients with cerebral hemorrhage [J]. Clinical Focus, 2021, 36(5): 425-431.
[11]	Zhang Linli, Ma Xiaohong. Clinical features and risk factors of acute kidney injury after hip fracture in the elderly [J]. Clinical Focus, 2021, 36(5): 442-445.
[12]	Zhang Jinjin, Jin Ruixia, Sun Wei. High-flux hemodialysis in the frailty of elderly patients with end-stage renal disease [J]. Clinical Focus, 2021, 36(4): 328-331.
[13]	He Lianyi. Application effect of different dialysis frequencies in uremic patients [J]. Clinical Focus, 2015, 30(11): 1292-1.29513e+007.
[14]	Niu Kaiya;Yang Fan;Yang Xiaoyan;Ye Jun;Cheng Jiejing. Diagnostic value of urinary liver-type fatty acid binding proteins and urinary neutrophil gelatinase-associated lipocalin in severe sepsis patients with acute kidney injury [J]. Clinical Focus, 2015, 30(5): 536-539.
[15]	Yu Qin;Xing Guangqun;Zhou Quan. Effects of neutrophil extracellular traps and contact system in uremic patients with acute coronary syndrome [J]. Clinical Focus, 2015, 30(5): 540-543544.